{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T00:41:25Z","timestamp":1794530485689,"version":"4.9.1"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,21]],"date-time":"2025-08-21T00:00:00Z","timestamp":1755734400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,8,21]],"date-time":"2025-08-21T00:00:00Z","timestamp":1755734400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-16137-8","type":"journal-article","created":{"date-parts":[[2025,8,21]],"date-time":"2025-08-21T07:19:57Z","timestamp":1755760797000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Clinical and laboratory predictors of mortality in Staphylococcus aureus bacteremia"],"prefix":"10.1038","volume":"15","author":[{"given":"Deniz","family":"Borcak","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusuf Emre","family":"Ozdemir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zuhal","family":"Yesilbag","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samiha","family":"Akkaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esra","family":"Ensaroglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aysegul Inci","family":"Sezen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esra Canbolat","family":"Unlu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatma Bayrak","family":"Erdem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sevtap","family":"Senoglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeynep","family":"Cizmeci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hayat Kumbasar","family":"Karaosmanoglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kadriye Kart","family":"Yasar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,21]]},"reference":[{"issue":"3","key":"16137_CR1","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1128\/CMR.00134-14","volume":"28","author":"SY Tong","year":"2015","unstructured":"Tong, S. Y., Davis, J. S., Eichenberger, E., Holland, T. L. & Fowler, V. G. Jr Staphylococcus aureus infections: epidemiology, pathophysiology, clinical manifestations, and management. Clin. Microbiol. Rev. 28 (3), 603\u2013661. https:\/\/doi.org\/10.1128\/CMR.00134-14 (2015).","journal-title":"Clin. Microbiol. Rev."},{"issue":"7","key":"16137_CR2","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1111\/jgs.15391","volume":"66","author":"M Bassetti","year":"2018","unstructured":"Bassetti, M. et al. Predictors of mortality with Staphylococcus aureus bacteremia in elderly adults. J. Am. Geriatr. Soc. 66 (7), 1284\u20131289. https:\/\/doi.org\/10.1111\/jgs.15391 (2018).","journal-title":"J. Am. Geriatr. Soc."},{"issue":"12","key":"16137_CR3","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1086\/502156","volume":"24","author":"O Lesens","year":"2003","unstructured":"Lesens, O. et al. Role of comorbidity in mortality related to Staphylococcus aureus bacteremia: a prospective study using the Charlson weighted index of comorbidity. Infect. Control Hosp. Epidemiol. 24 (12), 890\u2013896. https:\/\/doi.org\/10.1086\/502156 (2003).","journal-title":"Infect. Control Hosp. Epidemiol."},{"key":"16137_CR4","doi-asserted-by":"publisher","first-page":"961e71","DOI":"10.1007\/s15010-019-01330-5","volume":"47","author":"JC Lam","year":"2019","unstructured":"Lam, J. C. et al. Epidemiology and outcome determinants of Staphylococcus aureus bacteremia revisited: a population-based study. Infection 47, 961e71. https:\/\/doi.org\/10.1007\/s15010-019-01330-5 (2019).","journal-title":"Infection"},{"issue":"13","key":"16137_CR5","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.1001\/jama.2014.9743","volume":"312","author":"TL Holland","year":"2014","unstructured":"Holland, T. L., Arnold, C. & Fowler, V. G. Jr Clinical management of Staphylococcus aureus bacteremia: a review. JAMA 312 (13), 1330\u20131341. https:\/\/doi.org\/10.1001\/jama.2014.9743 (2014).","journal-title":"JAMA"},{"key":"16137_CR6","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1128\/CMR.05022-11","volume":"25","author":"SJ Van Hal","year":"2012","unstructured":"Van Hal, S. J. et al. Predictors of mortality in Staphylococcus aureus bacteremia. Clin. Microbiol. Rev. 25, 362\u2013386. https:\/\/doi.org\/10.1128\/CMR.05022-11 (2012).","journal-title":"Clin. Microbiol. Rev."},{"key":"16137_CR7","doi-asserted-by":"crossref","unstructured":"Cosgrove, S. E. et al. Comparison of mortality associated with methicillin-resistant and methicillin-susceptible Staphylococcus aureus.  Clin. Infect. Dis. 36 (1), 53\u201359 (2003).","DOI":"10.1086\/345476"},{"issue":"3","key":"16137_CR8","doi-asserted-by":"publisher","first-page":"e18","DOI":"10.1093\/cid\/ciq146","volume":"52","author":"C Liu","year":"2011","unstructured":"Liu, C. et al. Clinical practice guidelines by the infectious diseases society of America for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children. Clin. Infect. Dis. 52 (3), e18\u2013e55. https:\/\/doi.org\/10.1093\/cid\/ciq146 (2011).","journal-title":"Clin. Infect. Dis."},{"issue":"9","key":"16137_CR9","doi-asserted-by":"publisher","first-page":"625e1","DOI":"10.1016\/j.eimc.2015.03.015","volume":"33","author":"F Gudiol","year":"2015","unstructured":"Gudiol, F. et al. Diagnosis and treatment of bacteremia and endocarditis due to Staphylococcus aureus: a clinical guideline from the Spanish society of clinical microbiology and infectious diseases (SEIMC). Enferm Infecc Microbiol. Clin. 33 (9), 625e1\u2013625e23. https:\/\/doi.org\/10.1016\/j.eimc.2015.03.015 (2015).","journal-title":"Enferm Infecc Microbiol. Clin."},{"issue":"3","key":"16137_CR10","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1007\/s10096-023-04557-1","volume":"42","author":"M Papadimitriou-Olivgeris","year":"2023","unstructured":"Papadimitriou-Olivgeris, M., Caruana, G., Senn, L. & Guery, B. Predictors of mortality of Staphylococcus aureus bacteremia among patients hospitalized in a Swiss university hospital and the role of early source control; a retrospective cohort study. Eur. J. Clin. Microbiol. Infect. Dis. 42 (3), 347\u2013357   (2023).","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"issue":"3","key":"16137_CR11","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/0196-6553(88)90053-3","volume":"16","author":"JS Garner","year":"1988","unstructured":"Garner, J. S., Jarvis, W. R., Emori, T. G., Horan, T. C. & Hughes, J. M. CDC definitions for nosocomial infections. Am. J. Infect. Control. 16 (3), 128\u2013140. https:\/\/doi.org\/10.1016\/0196-6553(88)90053-3 (1988).","journal-title":"Am. J. Infect. Control"},{"issue":"4","key":"16137_CR12","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1086\/313753","volume":"30","author":"JS Li","year":"2000","unstructured":"Li, J. S. et al. Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis. Clin. Infect. Dis. 30 (4), 633\u2013638. https:\/\/doi.org\/10.1086\/313753 (2000).","journal-title":"Clin. Infect. Dis."},{"issue":"5","key":"16137_CR13","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","volume":"40","author":"ME Charlson","year":"1987","unstructured":"Charlson, M. E., Pompei, P., Ales, K. L. & MacKenzie, C. R. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J. Chronic Dis. 40 (5), 373\u2013383. https:\/\/doi.org\/10.1016\/0021-9681(87)90171-8 (1987).","journal-title":"J. Chronic Dis."},{"issue":"11","key":"16137_CR14","doi-asserted-by":"publisher","first-page":"e1063","DOI":"10.1097\/CCM.0000000000005337","volume":"49","author":"L Evans","year":"2021","unstructured":"Evans, L. et al. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021. Crit. Care Med. 49 (11), e1063\u2013e1143. https:\/\/doi.org\/10.1097\/CCM.0000000000005337 (2021).","journal-title":"Crit. Care Med."},{"key":"16137_CR15","unstructured":"COVID-19 Treatment Guidelines Panel. Coronavirus Disease 2019 [COVID-19] Treatment Guidelines. National Institutes of Health (2024, accessed 23 Jul 2024). https:\/\/www.covid19treatmentguidelines.nih.gov\/."},{"key":"16137_CR16","unstructured":"Performance Standards for Antimicrobial Susceptibility Testing. 27th ed. CLSI supplement M100 [Internet]. Wayne, AP: Clinical and Laboratory Standards Institute.  https:\/\/clsi.org\/media\/1469\/m100s27_sample.pdf (2024)."},{"key":"16137_CR17","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s12941-016-0122-8","volume":"15","author":"M Yilmaz","year":"2016","unstructured":"Yilmaz, M. et al. Mortality predictors of Staphylococcus aureus bacteremia: a prospective multicenter study. Ann. Clin. Microbiol. Antimicrob. 15, 7. https:\/\/doi.org\/10.1186\/s12941-016-0122-8 (2016).","journal-title":"Ann. Clin. Microbiol. Antimicrob."},{"issue":"8","key":"16137_CR18","doi-asserted-by":"publisher","first-page":"1666","DOI":"10.1093\/cid\/ciz498","volume":"70","author":"ED Austin","year":"2020","unstructured":"Austin, E. D. et al. Reduced mortality of Staphylococcus aureus bacteremia in a retrospective cohort study of 2139 patients: 2007\u20132015. Clin. Infect. Dis. 70 (8), 1666\u20131674. https:\/\/doi.org\/10.1093\/cid\/ciz498 (2020).","journal-title":"Clin. Infect. Dis."},{"issue":"5","key":"16137_CR19","doi-asserted-by":"publisher","first-page":"e0127385","DOI":"10.1371\/journal.pone.0127385","volume":"10","author":"V Le Moing","year":"2015","unstructured":"Le Moing, V. et al. Staphylococcus aureus bloodstream infection and Endocarditis\u2013A prospective cohort study. PloS One. 10 (5), e0127385. https:\/\/doi.org\/10.1371\/journal.pone.0127385 (2015).","journal-title":"PloS One"},{"issue":"1","key":"16137_CR20","doi-asserted-by":"publisher","first-page":"31","DOI":"10.36519\/idcm.2023.191","volume":"5","author":"T Yan\u0131k-Yal\u00e7\u0131n","year":"2023","unstructured":"Yan\u0131k-Yal\u00e7\u0131n, T., Erol, \u00c7., Demirkaya, M. H., Durukan, E. & Kurt-Azap, \u00d6. Evaluation of clinical approach and outcomes Staphylococcus aureus bacteremia. Infect. Dis. Clin. Microbiol. 5 (1), 31\u201339. https:\/\/doi.org\/10.36519\/idcm.2023.191 (2023).","journal-title":"Infect. Dis. Clin. Microbiol."},{"key":"16137_CR21","unstructured":"World health statistics 2023: monitoring health for the SDGs, Sustainable Development Goals. https:\/\/data.who.int\/indicators\/i\/5DD9606 (2023)."},{"issue":"2","key":"16137_CR22","doi-asserted-by":"publisher","first-page":"e0170236","DOI":"10.1371\/journal.pone.0170236","volume":"12","author":"M Bassetti","year":"2017","unstructured":"Bassetti, M. et al. Characteristics of Staphylococcus aureus bacteraemia and predictors of early and late mortality. PLoS One. 12 (2), e0170236. https:\/\/doi.org\/10.1371\/journal.pone.0170236 (2017).","journal-title":"PLoS One"},{"key":"16137_CR23","doi-asserted-by":"publisher","unstructured":"Kang, C. K. et al. Korea infectious diseases (KIND) study group. Gender affects prognosis of methicillin-resistant Staphylococcus aureus bacteremia differently depending on the severity of underlying disease. Eur. J. Clin. Microbiol. Infect. Dis. 37 (6), 1119\u20131123. https:\/\/doi.org\/10.1007\/s10096-018-3226-6 (2018 Jun).","DOI":"10.1007\/s10096-018-3226-6"},{"key":"16137_CR24","doi-asserted-by":"publisher","unstructured":"Seas, C. et al. Staphylococcus aureus bloodstream infections in Latin America: results of a multinational prospective cohort study. J. Antimicrob. Chemother.   73 (1), 212\u2013222. https:\/\/doi.org\/10.1093\/jac\/dkx350 (2018).","DOI":"10.1093\/jac\/dkx350"},{"issue":"6","key":"16137_CR25","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1086\/37754026","volume":"37","author":"SH Kim","year":"2003","unstructured":"Kim, S. H. et al. Outcome of Staphylococcus aureus bacteremia in patients with eradicable foci versus noneradicable foci. Clin. Infect. Dis. 37 (6), 794\u2013799. https:\/\/doi.org\/10.1086\/37754026 (2003).","journal-title":"Clin. Infect. Dis."},{"key":"16137_CR26","doi-asserted-by":"publisher","unstructured":"Blot, S. I., Vandewoude, K. H., Hoste, E. A. & Colardyn, F. A. Outcome and attributable mortality in critically ill patients with bacteremia involving methicillin-susceptible and methicillin-resistant Staphylococcus aureus. Arch. Intern. Med. 28 (19), 2229\u20132235. https:\/\/doi.org\/10.1001\/archinte.162.19.2229 (2002 Oct).","DOI":"10.1001\/archinte.162.19.2229"},{"issue":"9","key":"16137_CR27","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1080\/23744235.2017.1331463","volume":"49","author":"MU Hansen","year":"2017","unstructured":"Hansen, M. U. et al. Diabetes increases the risk of disease and death due to Staphylococcus aureus bacteremia. A matched case-control and cohort study. Infect. Dis. (Lond). 49 (9), 689\u2013697. https:\/\/doi.org\/10.1080\/23744235.2017.1331463 (2017).","journal-title":"Infect. Dis. (Lond)"},{"key":"16137_CR28","doi-asserted-by":"publisher","unstructured":"Hindy, J. R., Quintero-Martinez, J. A., Lahr, B. D., DeSimone, D. C. & Baddour, L. M. Staphylococcus aureus bacteraemia and mortality: a population-based study in olmsted county, minnesota, from 2006 to 2020. Infect Dis. (Lond.) 55(1), 1\u20138.  https:\/\/doi.org\/10.1080\/23744235.2022.2123561  (2023).","DOI":"10.1080\/23744235.2022.2123561"},{"key":"16137_CR29","doi-asserted-by":"publisher","unstructured":"Sharma, N., Schwendimann, R., Endrich, O., Ausserhofer, D. & Simon, M. Comparing Charlson and Elixhauser comorbidity indices with different weightings to predict in-hospital mortality: an analysis of national inpatient data. BMC Health Serv. Res.  21 (1), 13. https:\/\/doi.org\/10.1186\/s12913-020-05999-5 (2021).","DOI":"10.1186\/s12913-020-05999-5"},{"key":"16137_CR30","doi-asserted-by":"publisher","unstructured":"de la Ternavasio-, H. G. et al. The updated Charlson comorbidity index is a useful predictor of mortality in patients with Staphylococcus aureus bacteraemia. Epidemiol. Infect. 146 (16), 2122\u20132130. https:\/\/doi.org\/10.1017\/S0950268818002480 (2018).","DOI":"10.1017\/S0950268818002480"},{"issue":"11","key":"16137_CR31","doi-asserted-by":"publisher","first-page":"1975","DOI":"10.3390\/diagnostics13111975","volume":"13","author":"P Ioannou","year":"2023","unstructured":"Ioannou, P. et al. A retrospective study of Staphylococcus aureus bacteremia in a tertiary hospital and factors associated with mortality. Diagnostics (Basel). 13 (11), 1975. https:\/\/doi.org\/10.3390\/diagnostics13111975 (2023).","journal-title":"Diagnostics (Basel)"},{"issue":"5","key":"16137_CR32","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1086\/317421","volume":"31","author":"JM Mylotte","year":"2000","unstructured":"Mylotte, J. M. & Tayara, A. Staphylococcus aureus bacteremia: predictors of 30-day mortality in a large cohort. Clin. Infect. Dis. 31 (5), 1170\u20131174. https:\/\/doi.org\/10.1086\/317421 (2000).","journal-title":"Clin. Infect. Dis."},{"issue":"4","key":"16137_CR33","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/j.jcrc.2010.09.002","volume":"26","author":"MP Schreiber","year":"2011","unstructured":"Schreiber, M. P., Chan, C. M. & Shorr, A. F. Bacteremia in Staphylococcus aureus pneumonia: outcomes and epidemiology. J. Crit. Care. 26 (4), 395\u2013401. https:\/\/doi.org\/10.1016\/j.jcrc.2010.09.002 (2011).","journal-title":"J. Crit. Care"},{"issue":"7","key":"16137_CR34","doi-asserted-by":"publisher","first-page":"368","DOI":"10.5694\/j.1326-5377.2009.tb02841.x","volume":"191","author":"JD Turnidge","year":"2009","unstructured":"Turnidge, J. D. et al. Staphylococcus aureus bacteraemia: a major cause of mortality in Australia and new Zealand. Med. J. Aust. 191 (7), 368\u2013373. https:\/\/doi.org\/10.5694\/j.1326-5377.2009.tb02841.x (2009).","journal-title":"Med. J. Aust"},{"issue":"3","key":"16137_CR35","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1086\/512627","volume":"28","author":"S Shurland","year":"2007","unstructured":"Shurland, S., Zhan, M., Bradham, D. D. & Roghmann, M. C. Comparison of mortality risk associated with bacteremia due to methicillin-resistant and methicillin-susceptible Staphylococcus aureus. Infect. Control Hosp. Epidemiol. 28 (3), 273\u2013279. https:\/\/doi.org\/10.1086\/512627 (2007).","journal-title":"Infect. Control Hosp. Epidemiol."},{"key":"16137_CR36","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1007\/s10096-008-0515-5","volume":"27","author":"G Jacobsson","year":"2008","unstructured":"Jacobsson, G., Gustafsson, E. & Andersson, R. Outcome for invasive Staphylococcus aureus infections. Eur. J. Clin. Microbiol. Infect. Dis. 27, 839\u2013848 (2008).","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"16137_CR37","doi-asserted-by":"publisher","unstructured":"Whitenack, K. M., Ilges, D., Epps, K. L., McGary, A. & Robinson, J. C. Impact of hypoalbuminemia on clinical outcomes in patients receiving Cefazolin for Methicillin-Susceptible Staphylococcus aureus bacteremia. Ann. Pharmacother Published Online Febr. 19, 856. https:\/\/doi.org\/10.1177\/10600280251313874) (2025).","DOI":"10.1177\/10600280251313874)"},{"issue":"7","key":"16137_CR38","doi-asserted-by":"publisher","first-page":"474","DOI":"10.4149\/BLL_2021_078","volume":"122","author":"R Zahorec","year":"2021","unstructured":"Zahorec, R. Neutrophil-to-lymphocyte ratio, past, present and future perspectives. Bratisl Lek Listy. 122 (7), 474\u2013488. https:\/\/doi.org\/10.4149\/BLL_2021_078 (2021).","journal-title":"Bratisl Lek Listy"},{"key":"16137_CR39","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1186\/s13054-018-2025-x","volume":"22","author":"JA Greenberg","year":"2018","unstructured":"Greenberg, J. A. et al. Distinct T-helper cell responses to Staphylococcus aureus bacteremia reflect Immunologic comorbidities and correlate with mortality. Crit. Care. 22, 107. https:\/\/doi.org\/10.1186\/s13054-018-2025-x (2018).","journal-title":"Crit. Care"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-16137-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-16137-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-16137-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T18:10:27Z","timestamp":1757441427000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-16137-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,21]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["16137"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-16137-8","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,21]]},"assertion":[{"value":"26 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"not applicable. \u2018Due to the retrospective nature of the study, waived the need of obtaining informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human ethics and consent to participate"}},{"value":"This study was approved by the University of Health Sciences, Turkey, Bak\u0131rk\u00f6y Dr. Sadi Konuk Training and Research Hospital Clinical Research Ethics Committee (approval number: 2023-08-15, date:17.04.2023). This study complied with the Declaration of Helsinki.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}],"article-number":"30709"}}